TRPV2 and urinary bladder carcinoma: Similarly, treatment of the mouse bladder carcinoma cell line MBT-2 with TRPV2 agonists 2-APB or LPC induced Ca2+ influx and inhibited cell proliferation, but TRPV2 silencing induced an opposite effect [57].